InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Ashkenazi Anat, Chief Financial Officer. Insider active across 2 companies, notably Maravai Lifesciences Holdings, INC.. Cumulatively, 4 reports have been published. The latest transaction was disclosed on 9 February 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
€1m5,752 shares@ €212.99750.0001% mcap100.0% of flow
Common Stock
SEC:0000059478-22-000034·
€1m5,752 shares@ €212.99750.0001% mcap50.0% of flow
Common Stock
SEC:0000059478-22-000034:0·
04,271 shares0
Class A Common Stock
SEC:0000899243-21-045770·
04,271 shares0
Class A Common Stock
SEC:0000899243-21-045770:0·
4 of 4 declarations
About Ashkenazi Anat
Ashkenazi Anat is the Chief Financial Officer and Director at Maravai Lifesciences Holdings, Inc. and Eli Lilly & Co. In these roles, he oversees financial operations and contributes to the growth strategy of the companies. His expertise in finance and risk management is essential for ensuring the financial health and sustainability of the companies.
